Taysha Gene Therapies, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Taysha Gene Therapies, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q2 2024.
  • Taysha Gene Therapies, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 201M shares, a 213% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 201M +137M +213% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 187M +124M +195% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 187M +124M +196% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 187M +146M +354% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 64.4M +23.4M +57.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 63.5M +25M +65% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 63.2M +24.7M +64.3% Dec 31, 2022 10-K 2024-03-19
Q3 2022 41.2M +2.7M +7.02% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 41M +2.63M +6.85% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 38.5M +713K +1.89% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 38.5M +713K +1.89% Dec 31, 2021 10-K 2023-03-28
Q3 2021 38.5M +713K +1.89% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 38.4M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 37.8M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 37.8M +26.9M +247% Dec 31, 2020 10-K 2022-03-31
Q3 2020 37.8M Sep 30, 2020 10-Q 2020-11-12
Q4 2019 10.9M Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.